Clinical Trial Update: Pilot Study Evaluating the Safety and Efficacy of Open-Label Olanzapine [Phase 3]

View source ↗

Summary

A Phase 3 open-label pilot study assessing the safety and efficacy of olanzapine in bipolar disorder was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Zyprexa (olanzapine)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Bipolar Disorder | Phase 3 | Status: TERMINATED